Relationship between miRNA-338-3p expression and progression and prognosis of human colorectal carcinoma

Chinese Medical Journal

Volumn 127, Issue 10, 2014, Pages 1884-1890

  Sun, Kai ^a   Su, Gui Yuan ^a   Deng, Hai Jun ^a   Dong, Jing Qing ^a   Lei, Shang Tong ^a   Li, Guo Xin ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal carcinoma; miRNA 338 3p; Prognosis; Smoothened

Indexed keywords

MICRORNA; MICRORNA 338 3P; SMOOTHENED PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CELL DIFFERENTIATION; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; MALE; NORTHERN BLOTTING; OVERALL SURVIVAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; COLORECTAL TUMOR; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROGNOSIS;

ADULT; AGED; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS;

EID: 84900828820     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20140478     Document Type: Article

References (22)

1. Schetter AJ, Harris CC. Plasma microRNAs: a potential biomarker for colorectal cancer? Gut 2009; 58: 1318-1319.
2. Mirnezami AH, Pickard K, Zhang L, Primrose JN, Packham G. MicroRNAs: key players in carcinogenesis and novel therapeutic targets. Eur J Surg Oncol 2009; 35: 339-347.
3. Bartels CL, Tsongalis GJ. MicroRNAs: novel biomarkers for human cancer. Clin Chem 2009; 55: 623-631.
4. Tang JT, Fang JY. MicroRNA regulatory network in human colorectal cancer. Mini Rev Med Chem 2009; 9: 921-926.
5. Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H, et al. Over-and under-expressed microRNAs in human colorectal cancer. Int J Oncol 2009; 34: 1069-1075.
6. Wang CJ, Zhou ZG, Wang L, Yang L, Zhou B, Gu J, et al. Clinicopathological signifcance of microRNA-31, -143 and -145 expression in colorectal cancer. Dis Markers 2009; 26: 27-34.
7. Aschrafi A, Schwechter AD, Mameza MG, Natera-Naranjo O, Gioio AE, Kaplan BB. MicroRNA-338 regulates local cytochrome c oxidase IV mRNA levels and oxidative phosphorylation in the axons of sympathetic neurons. J Neurosci 2008; 28: 12581-12590.
8. Coon V, Laukert T, Pedone CA, Laterra J, Kim KJ, Fults DW. Molecular therapy targeting Sonic hedgehog and hepatocyte growth factor signaling in a mouse model of medulloblastoma. Mol Cancer Ther 2010; 9: 2627-2636.
9. Stanton BZ, Peng LF. Small-molecule modulators of the Sonic Hedgehog signaling pathway. Mol Biosyst 2010; 6: 44-54.
10. Schneider FT, Schänzer A, Czupalla CJ, Thom S, Engels K, Schmidt MH, et al. Sonic hedgehog acts as a negative regulator of {beta}-catenin signaling in the adult tongue epithelium. Am J Pathol 2010; 177: 404-414.
11. Liu Y, Zhao JJ, Wang CM, Li MY, Han P, Wang L, et al. Altered expression profles of microRNAs in a stable hepatitis B virus-expressing cell line. Chin Med J 2009; 122: 10-14.
12. Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 2010; 11: 136-146.
13. Sun K, Zeng JJ, Wang W, Wu CT, Lei ST, Li GX. MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma. Acta Pharmacol Sin 2011; 32: 375-384.
14. Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res 2004; 14: 1902-1910.
15. Tsuchiya S, Oku M, Imanaka Y, Kunimoto R, Okuno Y, Terasawa K, et al. MicroRNA-338-3p and microRNA-451 contribute to the formation of basolateral polarity in epithelial cells. Nucleic Acids Res 2009; 37: 3821-3827.
16. Huang XH, Wang Q, Chen JS, Fu XH, Chen XL, Chen LZ, et al. Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is down-regulated. Hepatology Res 2009; 39: 786-794.
17. Wang K, Pan L, Che X, Cui D, Li C. Sonic Hedgehog/GLI signaling pathway inhibition restricts cell migration and invasion in human gliomas. Neurol Res 2010; 32: 975-980.
18. Mirnezami AH, Pickard K, Zhang L, Primrose JN, Packham G. MicroRNAs: key players in carcinogenesis and novel therapeutic targets. Eur J Surg Oncol 2009; 35: 339-347.
19. Baffa R, Fassan M, Volinia S, O'Hara B, Liu CG, Palazzo JP, et al. MicroRNA expression profling of human metastatic cancers identifes cancer gene targets. J Pathol 2009; 219: 214-221.
20. Fabbri M. MiRNAs as molecular biomarkers of cancer. Expert Rev Mol Diagn 2010; 10: 435-444.
21. Heneghan HM, Miller N, Kerin MJ. MiRNAs as biomarkers and therapeutic targets in cancer. Curr Opin Pharmacol 2010; 10: 543-550.
22. Huang XH, Chen JS, Wang Q, Chen XL, Wen L, Chen LZ, et al. miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened. J Pathol 2011; 225: 463-472.